Proton MR spectroscopy - Detectable major neurotransmitters of the brain: Biology and possible clinical applications

American Journal of Neuroradiology

Volumn 33, Issue 4, 2012, Pages 595-602

  Agarwal, Nivedita ^a,b   Renshaw, P F ^b  

^a SANTA CHIARA HOSPITAL   (Italy)

^b The Brain Institute at the University of Utah   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINE; ETIRACETAM; FLUORODEOXYGLUCOSE F 18; GABAPENTIN; GALANTAMINE; GLUTAMIC ACID; INOSITOL; IONOTROPIC RECEPTOR; MEMANTINE; N ACETYLASPARTYLGLUTAMIC ACID; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; RILUZOLE; TOPIRAMATE; VIGABATRIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN NERVE CELL; BRAIN TUMOR; DIAGNOSTIC ACCURACY; EPILEPSY; EXCITOTOXICITY; GABAERGIC TRANSMISSION; HUMAN; HUNTINGTON CHOREA; INTERNEURON; MIGRAINE; NEUROBIOLOGY; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; REVIEW; SYNAPSE; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; BRAIN; BRAIN DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEUROTRANSMITTER AGENTS; PROTONS; TISSUE DISTRIBUTION;

EID: 84860257783     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2587     Document Type: Review

References (72)

1. Braitenberg V, Schüz A. Cortex: Statistics and Geometry of Neuronal Connectivity. Berlin, Germany: Springer-Verlag; 1998
2. Shen J, Petersen KF, Behar KL, et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A 1999;96:8235-40 (Pubitemid 29328438)
3. Attwell D, Laughlin SB.Anenergy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001;21:1133-45 (Pubitemid 32947479)
4. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 1994;91:10625-29 (Pubitemid 24329051)
5. Sibson NR, Dhankhar A, Mason GF, et al. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A 1998;95:316-21 (Pubitemid 28103951)
6. van den Berg CJ, Garfinkel D. A simulation study of brain compartments: metabolism of glutamate and related substances in mouse brain. Biochem J 1971;123:211-18
7. Pellerin L, Bouzier-Sore AK, Aubert A, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 2007;55:1251-62 (Pubitemid 47235366)
8. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37 (Pubitemid 27238875)
9. Corti C, Battaglia G, Molinaro G, et al. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. J Neurosci 2007;27:8297-308 (Pubitemid 47219630)
10. Kvamme E, Schousboe A, Hertz L, et al. Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo. Neurochem Res 1985;10:993-1008 (Pubitemid 15009822)
11. Beart PM, O'Shea RD. Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 2007;150:5-17 (Pubitemid 46094664)
12. Esclapez M, Tillakaratne NJ, Kaufman DL, et al. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 1994;14:1834-55 (Pubitemid 24080030)
13. Wu H, Jin Y, Buddhala C, et al. Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles: evidence from GAD65-knockout mice studies. Brain Res 2007;1154:80-83 (Pubitemid 46856351)
14. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993;60:395-407 (Pubitemid 23030931)
15. Gadea A, Lopez-Colome AM. Glial transporters for glutamate, glycine, and GABA. II. GABA transporters. J Neurosci Res 2001;63:461-68 (Pubitemid 32193703)
16. Chatton JY, Pellerin L, Magistretti PJ. GABA uptake into astrocytes is not associated with significant metabolic cost: implications for brain imaging of inhibitory transmission. Proc Natl Acad Sci U S A 2003;100:12456-61 (Pubitemid 37271581)
17. Cherubini E, Conti F. Generating diversity at GABAergic synapses. Trends Neurosci 2001;24:155-62 (Pubitemid 32166820)
18. Pouwels PJ, Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997;10:73-78 (Pubitemid 27332604)
19. Gehl LM, Saab OH, Bzdega T, et al. Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J Neurochem 2004;90:989-97 (Pubitemid 39099981)
20. Wroblewska B, Santi MR, Neale JH. N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 1998;24:172-79 (Pubitemid 28403995)
21. Bergeron R, Coyle JT, Tsai G, et al. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology 2005;30:7-16 (Pubitemid 40024394)
22. Baslow MH. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target. Drug News Perspect 2008;21:251-57
23. Baslow MH, Guilfoyle DN. Using proton magnetic resonance imaging and spectroscopy to understand brain "activation." Brain Lang 2007;102:153-64 (Pubitemid 46962665)
24. Baslow MH, Dyakin VV, Nowak KL, et al. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia. J Mol Neurosci 2005;26:1-15 (Pubitemid 41003422)
25. Hayashi T. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn J Physiol 1952;3:46-64
26. Chapman AG. Glutamate and epilepsy. J Nutr 2000;130:1043S-45S (Pubitemid 30173641)
27. Jabs R, Seifert G, Steinhauser C. Astrocytic function and its alteration in the epileptic brain. Epilepsia 2008;49(suppl 2):3-12 (Pubitemid 351143761)
28. la Fougere C, Rominger A, Forster S, et al. PET and SPECT in epilepsy: a critical review. Epilepsy Behav 2009;15:50-55. Epub 2009 Feb 21
29. Pfund Z, Chugani DC, Juhasz C, et al. Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. J Cereb Blood Flow Metab 2000;20:871-78 (Pubitemid 30317062)
30. White HS, Smith MD, Wilcox KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol 2007;81:85-110
31. Pacheco Otalora LF, Moffett JR, Garrido-Sanabria ER. Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy. Brain Res 2007;1144:219-30 (Pubitemid 46440851)
32. Meyerhoff JL, Carter RE, Yourick DL, et al. Activity of a NAAG-hydrolyzing enzyme in brain may affect seizure susceptibility in genetically epilepsyprone rats. Epilepsy Res Suppl 1992;9:163-72
33. Petroff OA, Rothman DL, Behar KL, et al. Low brain GABA level is associated with poor seizure control. Ann Neurol 1996;40:908-11 (Pubitemid 27044609)
34. Petroff OA, Hyder F, Collins T, et al. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures. Epilepsia 1999;40:958-64 (Pubitemid 29316051)
35. Woermann FG, McLean MA, Bartlett PA, et al. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 1999;45:369-76 (Pubitemid 29120042)
36. Simister RJ, McLean MA, Barker GJ, et al. Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection. Epilepsy Res 2009;83:168-76
37. Ulu MO, Tanriverdi T, Oz B, et al. The expression of astroglial glutamate transporters in patients with focal cortical dysplasia: an immunohistochemical study. Acta Neurochir (Wien) 2010;152:845-53. Epub 2009 Oct 27
38. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9 (Pubitemid 23360802)
39. Aggarwal S, Cudkowicz M. ALS drug development: reflections from the past and a way forward. Neurotherapeutics 2008;5:516-27
40. Choi JK, Kustermann E, Dedeoglu A, et al. Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur J Neurosci 2009;30:2143-50. Epub 2009 Nov 20
41. Han J, Ma L. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 2010;31:305-08
42. Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006;52:39-59 (Pubitemid 44466358)
43. Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990;28:18-25 (Pubitemid 20222147)
44. Tsai GC, Stauch-Slusher B, Sim L, et al. Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS. Brain Res 1991;556:151-56
45. Rupsingh R, Borrie M, Smith M, et al. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging 2011;32:802-10. Epub 2009 Jun 6
46. Marjanska M, Curran GL, Wengenack TM, et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 2005;102:11906-10 (Pubitemid 41170823)
47. Glodzik L, King KG, Gonen O, et al. Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1005-12 (Pubitemid 351609238)
48. Penner J, Rupsingh R, Smith M, et al. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:104-10
49. Griffith HR, den Hollander JA, Okonkwo OC, et al. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia. Alzheimers Dement 2008;4:421-27
50. Tkac I, Dubinsky JM, Keene CD, et al. Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem 2007;100:1397- 406. Epub 2007 Jan 8
51. Reynolds NC, ProstRW,Mark LP, et al. MR-spectroscopic findings in juvenileonset Huntington's disease. Mov Disord 2008;23:1931-35
52. Theberge J, Williamson KE, Aoyama N, et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry 2007;191:325-34 (Pubitemid 47555981)
53. Agarwal N, Port JD, Bazzocchi M, et al. Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology 2010;255:23-41
54. Epperson CN, Gueorguieva R, Czarkowski KA, et al. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl) 2006;186:425-33 (Pubitemid 43800843)
55. DeVito TJ, Drost DJ, Pavlosky W, et al. Brain magnetic resonance spectroscopy in Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2005;44:1301-08 (Pubitemid 41669109)
56. Kickler N, Krack P, Fraix V, et al. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength. NMR Biomed 2007;20:757-62 (Pubitemid 350285273)
57. Bogner W, Gruber S, Doelken M, et al. In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS: how reproducible are the results? Eur J Radiol 2010;73:526-31
58. Provencher SW, Hänicke W, Michaelis T. Automated quantitation of localized 1HMR spectra in vivo: capabilities and limitations. In: Proceedings of the Third Scientific Meeting of the Society of Magnetic Resonance, Nice, France; August 19-25, 1995
59. Simister RJ, McLean MA, Barker GJ, et al. MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 2003;61:897-902 (Pubitemid 37248641)
60. Taki MM, Harada M, Mori K, et al. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI instrument. Neuroimage 2009;47:1207-14
61. Stagg CJ, Lang B, Best JG, et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010;51:1898-901
62. Simister RJ, Mclean MA, Barker GJ, et al. Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy. Epilepsy Res 2007;74:107-15 (Pubitemid 46667222)
63. Lin K, Carrete H Jr, Lin J, et al. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy. Epilepsia 2009;60:1191-2000
64. Doelken MT, Hammen T, Bogner W, et al. Alterations of intracerebral γ-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies. Epilepsia 2010;51:1477-82
65. Mueller SG, Weber OM, Duc CO, et al. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMRspectroscopy: responder characteristics. Epilepsia 2001;42:29-40 (Pubitemid 32171481)
66. Petroff OA, Hyder F, Rothman DL, et al. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 2001;42:543-48 (Pubitemid 32322201)
67. Rijpkema M, Schuuring J, van der Meulen Y, et al. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 2003;16:12-18 (Pubitemid 36284831)
68. Prescot A, Becerra L, Pendse G, et al. Excitatory neurotransmitters in brain regions in interictal migrane patients. Mol Pain 2009;5:34
69. Antuono PG, Jones JL, Wang Y, et al. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T. Neurology 2001;56:737-42 (Pubitemid 32240092)
70. Hattori N, Abe K, Sakoda S, et al. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease. Neuroreport 2002;13:183-86 (Pubitemid 34102052)
71. Glodzik L, King KG, Gonen O, et al. Memantine decreases hippocampal glutamate level: a magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1005-12 (Pubitemid 351609238)
72. Oz G, Terpstra M, Tkać I, et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med 2006;55:296-301 (Pubitemid 43238097)